This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Oliver Ross Steward: Innovator in Autotaxin Inhibitors
Introduction
Oliver Ross Steward is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of autotaxin inhibitors. With a total of two patents to his name, Steward's work is recognized for its potential impact on various diseases and disorders.
Latest Patents
Steward's latest patents focus on novel compounds that act as autotaxin inhibitors. The inventions detail processes for their preparation, pharmaceutical compositions, and medicaments containing these compounds. These innovations aim to address diseases and disorders mediated by autotaxin, showcasing Steward's commitment to advancing medical science.
Career Highlights
Oliver Ross Steward is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Steward has worked alongside notable colleagues such as David Beattie and Urs Baettig. Their combined expertise enhances the innovative efforts within their projects, fostering a collaborative environment that drives success.
Conclusion
Oliver Ross Steward is a distinguished inventor whose work on autotaxin inhibitors holds promise for the future of medicine. His contributions to Novartis AG and collaboration with esteemed colleagues further solidify his impact in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile